STOCK TITAN

CVS Pharmacy® introduces enhanced flu testing and treatment offerings

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

CVS Health (NYSE: CVS) has expanded its flu testing and treatment services across select locations. The company has introduced a new 3-in-1 combo test for Influenza A, Influenza B, and COVID-19 at approximately 1,600 locations in 37 states. In 13 states, pharmacists can both test and prescribe antiviral treatment in a single appointment.

The pharmacy-administered combo test costs $29.99, with an additional $45 pharmacist assessment fee. CVS also offers at-home combo test options priced between $12.99 and $24.99. The company provides various delivery options, including same-day and 1-2-day delivery for eligible prescriptions.

Additionally, CVS continues to offer flu and updated 2024-2025 COVID-19 vaccines at CVS Pharmacy and MinuteClinic locations nationwide. Patients 65 and older who received the updated COVID-19 vaccine in fall 2024 are eligible for a second dose after six months.

CVS Health (NYSE: CVS) ha ampliato i suoi servizi di test e trattamento per l'influenza in alcune località selezionate. L'azienda ha introdotto un nuovo test combinato 3-in-1 per l'Influenza A, l'Influenza B e il COVID-19 in circa 1.600 località in 37 stati. In 13 stati, i farmacisti possono sia effettuare test che prescrivere trattamenti antivirali in un'unica appuntamento.

Il test combinato somministrato in farmacia costa $29.99, con una tassa aggiuntiva di $45 per la valutazione del farmacista. CVS offre anche opzioni di test combinati da utilizzare a casa, con prezzi compresi tra $12.99 e $24.99. L'azienda fornisce varie opzioni di consegna, tra cui la consegna lo stesso giorno e quella in 1-2 giorni per le prescrizioni idonee.

Inoltre, CVS continua a offrire vaccini contro l'influenza e vaccini aggiornati per il COVID-19 2024-2025 presso le farmacie CVS e le MinuteClinic in tutto il paese. I pazienti di 65 anni e oltre che hanno ricevuto il vaccino aggiornato per il COVID-19 nell'autunno del 2024 sono idonei per una seconda dose dopo sei mesi.

CVS Health (NYSE: CVS) ha ampliado sus servicios de pruebas y tratamiento para la gripe en ubicaciones seleccionadas. La compañía ha introducido una nueva prueba combinada 3 en 1 para la Influenza A, la Influenza B y el COVID-19 en aproximadamente 1,600 ubicaciones en 37 estados. En 13 estados, los farmacéuticos pueden realizar pruebas y prescribir tratamientos antivirales en una sola cita.

La prueba combinada administrada en la farmacia cuesta $29.99, con una tarifa adicional de $45 por la evaluación del farmacéutico. CVS también ofrece opciones de pruebas combinadas para hacer en casa, con precios que oscilan entre $12.99 y $24.99. La compañía proporciona varias opciones de entrega, incluyendo entrega el mismo día y en 1-2 días para recetas elegibles.

Además, CVS sigue ofreciendo vacunas contra la gripe y vacunas actualizadas para el COVID-19 2024-2025 en las farmacias CVS y en las ubicaciones de MinuteClinic en todo el país. Los pacientes de 65 años o más que recibieron la vacuna actualizada contra el COVID-19 en otoño de 2024 son elegibles para una segunda dosis después de seis meses.

CVS Health (NYSE: CVS)는 선택된 장소에서 독감 검사 및 치료 서비스를 확대했습니다. 이 회사는 약 1,600개 지점에서 인플루엔자 A, 인플루엔자 B 및 COVID-19를 위한 새로운 3-in-1 조합 검사를 도입했습니다. 13개 주에서는 약사가 한 번의 예약으로 검사와 항바이러스 치료를 모두 수행할 수 있습니다.

약국에서 시행되는 조합 검사 비용은 $29.99이며, 약사 평가 수수료로 추가 $45가 부과됩니다. CVS는 또한 $12.99에서 $24.99 사이의 가격으로 집에서 사용할 수 있는 조합 검사 옵션을 제공합니다. 이 회사는 적격 처방약에 대해 당일 및 1-2일 배송을 포함한 다양한 배송 옵션을 제공합니다.

추가로, CVS는 전국의 CVS 약국과 MinuteClinic 위치에서 독감 및 2024-2025년 업데이트된 COVID-19 백신을 계속 제공하고 있습니다. 2024년 가을에 업데이트된 COVID-19 백신을 접종한 65세 이상의 환자는 6개월 후 두 번째 접종을 받을 수 있습니다.

CVS Health (NYSE: CVS) a élargi ses services de dépistage et de traitement de la grippe dans certaines localités sélectionnées. L'entreprise a introduit un nouveau test combiné 3-en-1 pour la grippe A, la grippe B et le COVID-19 dans environ 1 600 lieux dans 37 États. Dans 13 États, les pharmaciens peuvent à la fois tester et prescrire un traitement antiviral lors d'un même rendez-vous.

Le test combiné administré en pharmacie coûte $29.99, avec des frais d'évaluation du pharmacien supplémentaires de $45. CVS propose également des options de tests combinés à domicile, dont les prix varient entre $12.99 et $24.99. L'entreprise offre diverses options de livraison, y compris la livraison le jour même et la livraison en 1 à 2 jours pour les prescriptions éligibles.

De plus, CVS continue de proposer des vaccins contre la grippe et des vaccins COVID-19 mis à jour pour 2024-2025 dans les pharmacies CVS et les sites MinuteClinic à travers le pays. Les patients de 65 ans et plus ayant reçu le vaccin COVID-19 mis à jour à l'automne 2024 sont éligibles pour une deuxième dose après six mois.

CVS Health (NYSE: CVS) hat seine Test- und Behandlungsdienste für Grippe an ausgewählten Standorten ausgeweitet. Das Unternehmen hat einen neuen 3-in-1-Kombitest für Influenza A, Influenza B und COVID-19 an etwa 1.600 Standorten in 37 Bundesstaaten eingeführt. In 13 Bundesstaaten können Apotheker sowohl Tests durchführen als auch antivirale Behandlungen in einem einzigen Termin verschreiben.

Der in der Apotheke durchgeführte Kombitest kostet $29.99, zuzüglich einer Gebühr von $45 für die Bewertung durch den Apotheker. CVS bietet auch Kombitest-Optionen für zu Hause an, die zwischen $12.99 und $24.99 kosten. Das Unternehmen bietet verschiedene Lieferoptionen an, einschließlich der Lieferung am selben Tag und der Lieferung innerhalb von 1-2 Tagen für berechtigte Rezepte.

Darüber hinaus bietet CVS weiterhin Grippe- und aktualisierte COVID-19-Impfstoffe für 2024-2025 in CVS-Apotheken und MinuteClinic-Standorten im ganzen Land an. Patienten ab 65 Jahren, die im Herbst 2024 den aktualisierten COVID-19-Impfstoff erhalten haben, sind nach sechs Monaten für eine zweite Dosis berechtigt.

Positive
  • Expansion of testing services to 1,600 locations across 37 states
  • New revenue stream from combo testing ($29.99) and assessment fees ($45)
  • Additional revenue potential from at-home test sales ($12.99-$24.99)
  • Streamlined digital scheduling system implementation
Negative
  • treatment authorization to only 13 states
  • Service fees may not be fully covered by insurance

As flu cases continue to remain high, select CVS pharmacies across 37 states launch combo test for Flu A, Flu B and COVID-19

Pharmacists can also prescribe flu treatment for eligible patients in 13 states with positive test results helping ensure timely access to care

WOONSOCKET, R.I., Feb. 27, 2025 /PRNewswire/ -- With flu cases continuing to remain high in communities across the U.S., CVS Health® (NYSE: CVS) today announced that CVS Pharmacy® has enhanced its flu testing and treatment capabilities at roughly 1,600 locations in select states.

Participating CVS Pharmacy locations in 37 states have begun using a new 3-in-1 combo test when patients present with flu-like symptoms, allowing them to be tested for Influenza A, Influenza B, and COVID-19 with one swab.

In addition, the company has streamlined scheduling for test and treat appointments through its digital scheduler on CVS.com and the CVS Health app. In states that allow pharmacists to both test and treat for COVID-19 and flu, patients may now be tested and assessed by a CVS pharmacist for antiviral treatment in one appointment. Participating states include California, Colorado, Idaho, Illinois, Michigan, Minnesota, Montana, Nebraska, South Dakota, Tennessee, Washington, Wisconsin, and Wyoming.

"Timely access to care and treatment is critical with illnesses like influenza and COVID-19," said Jinali Desai, PharmD, MBA, MPH, Vice President, Pharmacy Health Services for CVS Health. "CVS Pharmacy's array of testing and treatment options allows us to be with our patients every step of the way. From immunizations to symptom evaluation to prescribing medications for those who are eligible, our trusted pharmacists offer convenient and accessible care when patients need us most."

A pharmacy-administered flu and COVID-19 test costs $29.99. The pharmacist assessment will cost $45, regardless of whether medication is prescribed. Patients may use HSA or FSA funds to cover the assessment fee. Any cost or copay for a prescribed medication is dependent on the patient's prescription insurance coverage.

At-Home Test Options

CVS Pharmacy offers several at-home flu and COVID-19 test options as well, enabling patients to test for these illnesses in the comfort of their own home. Three different combo tests, priced at $12.99 and $24.99, are available for purchase on CVS.com and at the company's retail stores nationwide.  

If a patient tests positive at-home and is seeking treatment, they can request a pharmacist evaluation via CVS.com or the CVS Health app and, if clinically appropriate, may be prescribed a medication. Pharmacist evaluations are available during weekend and evening hours. 

"Through our clinical pharmacy care offerings and extensive selection over-the-counter wellness products, we can help people with all of their wellness needs," added Desai.  

To make it even more convenient, CVS Pharmacy offers several delivery options for customers and patients with eligible prescriptions, including same-day delivery and 1-2-day delivery.

Help prevent illness with immunizations

Immunization is the most effective way to help prevent the flu. Both the flu vaccine and updated 2024-2025 COVID-19 vaccine are still available at CVS Pharmacy® and MinuteClinic® locations nationwide. MinuteClinic also offers sick symptom visits during which patients can be tested for flu, COVID-19, and strep throat, if eligible. Walk-ins are accepted at CVS Pharmacy and the company's digital vaccine scheduler reflects available appointments at CVS Pharmacy and MinuteClinic.

Patients ages six months and older should receive the updated flu and COVID-19 vaccine to restore and enhance protection against the most prevalent virus variants currently circulating. While the ideal time to receive a flu shot is before the winter months, it's not too late to get an updated dose. 

In addition, people age 65 and older who received the updated COVID-19 vaccine in the fall of 2024 can receive a second dose six months after the first. People who are moderately or severely immunocompromised are eligible for a second dose as well. This means that patients who received an updated COVID-19 in September or October 2024 would be eligible for another dose in March or April 2025. 

Video and photo assets from CVS Pharmacy and MinuteClinic are available here.

About CVS Health
CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health — whether that's managing chronic diseases, staying compliant with their medications, or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system — and their personal health care — by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.

Media contact
Amy Thibault
401-318-2865
Amy.Thibault@CVSHealth.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-pharmacy-introduces-enhanced-flu-testing-and-treatment-offerings-302387520.html

SOURCE CVS Health

FAQ

How much does CVS charge for the new 3-in-1 flu and COVID test?

CVS charges $29.99 for the pharmacy-administered combo test, plus a $45 pharmacist assessment fee if treatment is needed.

In which states can CVS pharmacists both test and prescribe flu treatment?

CVS pharmacists can test and treat flu in 13 states: California, Colorado, Idaho, Illinois, Michigan, Minnesota, Montana, Nebraska, South Dakota, Tennessee, Washington, Wisconsin, and Wyoming.

What at-home testing options does CVS offer for flu and COVID-19?

CVS offers three different combo test options for at-home use, priced between $12.99 and $24.99, available online and in stores.

How many CVS locations offer the new 3-in-1 combo testing service?

The new 3-in-1 combo testing service is available at approximately 1,600 CVS Pharmacy locations across 37 states.

Cvs Health Corp

NYSE:CVS

CVS Rankings

CVS Latest News

CVS Stock Data

81.30B
1.26B
0.34%
82.02%
1.35%
Healthcare Plans
Retail-drug Stores and Proprietary Stores
Link
United States
WOONSOCKET